Cancer immunotherapy: A review

ADVANCEMENTS IN TUMOR IMMUNOTHERAPY AND CANCER VACCINES

228 p | 84 | 18

Comparative efficacy and safety of immunotherapy for patients with advanced or metastatic esophageal squamous cell carcinoma: A systematic review and network Meta-analysis

12 p | 5 | 3

Neoadjuvant immunotherapy and chemotherapy regimens for the treatment of high-risk, early-stage triple-negative breast cancer: A systematic review and network meta-analysis

13 p | 5 | 2

Rare, late onset of immune checkpoint inhibitor-induced type 1 diabetes mellitus in a patient with small-cell lung cancer treated with serplulimab: A case report and review of the literature

7 p | 6 | 2

Immunotherapy combined with apatinib in the treatment of advanced or metastatic gastric/gastroesophageal tumors: A systematic review and meta-analysis

18 p | 1 | 1

The safety and tolerability of combined immune checkpoint inhibitors (anti-PD-1/ PD-L1 plus anti-CTLA-4): A systematic review and meta-analysis

10 p | 10 | 1

Optimal biological dose: A systematic review in cancer phase I clinical trials

10 p | 13 | 1

Exceptional response to chemotherapy followed by concurrent radiotherapy and immunotherapy in a male with primary retroperitoneal serous Adenocarcinoma: A case report and literature review

7 p | 7 | 0